About
I am an academic medical oncologist with a clinical and research interest in oncology drug development, translational therapeutics and medical education. I have completed a Clinical Research Fellowship in Drug Development at the Princess Margaret Cancer Centre in Toronto, Canada and have established a firm interest in clinical development of novel therapeutics, especially pertaining to sarcoma medical oncology, neuro-oncology and thoracic oncology.
Other Appointments
- Ethics Committee Member, Phase 1 Clinical Research Ethics Research Committee, Joint CUHK-NTEC Clinical Ethics Research Committee, The Chinese University of Hong Kong / Hospital Authority, Hong Kong SAR
- Joint Scientific Committee (JSC) Panelist, Joint Scientific Committee for Phase 1 Trials, The University of Hong Kong, The Chinese University of Hong Kong & Hospital Authority, Hong Kong, Hong Kong SAR
- Working Group Member, Cancer Expert Working Group (CEWG) on Cancer Prevention & Screening, Centre for Health Protection, Department of Health, Government of the Hong Kong SAR
- Board Member, Drug & Poisons Board, Department of Health, Government of the Hong Kong SAR
- Committee Member, Cancer Prevention Working Group, Department of Health, Government of the Hong Kong
- Faculty Board Member, Faculty of Medicine, The Chinese University of Hong Kong
- Convener, Adult Sarcoma Multi-disciplinary Tumour Board, Prince of Wales Hospital
- Accredited Trainer in Medical Oncology, Hong Kong College of Physicians
- Scientific Committee Member, Sarcoma Track, American Society of Clinical Oncology Annual Meeting
- Membership Committee Member, International Association for the Study of Lung Cancer (IASLC)
- Previously Committee Member in International Affairs Committee and Asia-Pacific Regional Council, American Society of Clinical Oncology (ASCO)
Key Accomplishments
- Established the first multidisciplinary sarcoma tumour board in Hong Kong
- Established an international multidisciplinary sarcoma conference – “CUHK Sarcoma Masterclass” with annual attendance of over 100 medical professionals
- Established multiple collaborative clinical and translational research platforms in the Asia-Pacific region, including Asia Phase 1 Oncology Consortium (AsiaOne) and Asia Pacific Oncology Drug Development Consortium (APODDC)
Education / Honors
- 2018 International Association for Lung Cancer (IASLC) Foundation Lung Cancer Care Team Award (For best thoracic oncology team in Asia & Rest of World)
- 2017 & 2018 Exemplary Teachers’ Award, Department of Medicine & Therapeutics, The Chinese University of Hong Kong
- 2016 International Educational Travel Sponsorship, Hong Kong Neuro-Oncology Society
- 2014 Merit Award, American Society of Clinical Oncology Annual Meeting, Chicago, IL, US
Please Leave a Review or Suggestion